Literature DB >> 12940826

Guillain-Barré syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnoses.

H Rauschka1, K Jellinger, H Lassmann, F Braier, M Schmidbauer.   

Abstract

In cases with otherwise clinically typical Guillain-Barré syndrome (GBS), pronounced cerebrospinal fluid (CSF) pleocytosis or the mere presence of CSF-polymorphonuclear granulocytes should alert the physician to consider alternative diagnoses. Therefore, we retrospectively studied the neuropathology of central and peripheral nervous system in two cases with a CSF cell count of more than 50/microl and in three cases with a significant proportion of polymorphonuclear granulocytes in the CSF sediment. All cases fulfilled the required criteria for the diagnosis of GBS, the duration from onset to death ranged from 4 to 100 days. Neuropathological investigations included routine staining procedures and immunohistochemistry for antigens of glial and haematopoetic cells as well as for products of relevant neurotropic viruses. Demyelinating polyradiculitis was present in four cases, in one patient with a survival time of 4 days the type of damage to myelinated fibres was unclassifiable. In the central nervous system a consistent finding was diffuse activation of microglia, only one case showed mild meningeal and lower brainstem inflammation. Viral products were generally absent. In summary, the neuropathological findings confirm that marked CSF pleocytosis or the presence of polymorphonuclear granulocytes does not rule out the diagnosis of GBS.

Entities:  

Mesh:

Year:  2003        PMID: 12940826     DOI: 10.1046/j.1468-1331.2003.00644.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  4 in total

1.  Miller Fisher syndrome--a presenting clinical manifestation of lung cancer in a previously apparently healthy individual.

Authors:  Tünde Csépány; Judit Boczán; Mária T Magyar; Sándor Molnár; László Csiba; Judit Décsy; Judit Tóth; Szabolcs Felszeghy; Szabolcs Szakáll; Zsolt Szentkereszty; Dániel Bereczki
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

2.  α(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro.

Authors:  Nejla Yosef; Eroboghene E Ubogu
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

Review 3.  Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?

Authors:  Johannes Brettschneider; Axel Petzold; Sigurd Süssmuth; Hayrettin Tumani
Journal:  J Neurol       Date:  2009-02-16       Impact factor: 4.849

4.  Anti-GQ1b-Negative Miller Fisher Syndrome with Acute Areflexic Mydriasis and Cholinergic Supersensitivity.

Authors:  Özlem Kayım Yıldız; Hatice Balaban; Sibel Özdemir; Ertuğrul Bolayır; Suat Topaktas
Journal:  Neuroophthalmology       Date:  2011-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.